The biotech market in the United States is experiencing a rapid surge in demand for Tirzepatide APIs. This effective medication, used to treat type 2 diabetes, has gained extensive attention from both individuals and doctors. As a result, numerous companies have emerged as suppliers of Tirzepatide APIs in the USA. Well-known Tirzepatide API manu